miR-27b inhibits LDLR and ABCA1 expression but does not influence plasma and hepatic lipid levels in mice

RATIONALE: Recently, there has been significant interest in the therapeutic administration of miRNA mimics and inhibitors to treat cardiovascular disease. In particular, miR-27b has emerged as a regulatory hub in cholesterol and lipid metabolism and potential therapeutic target for treating atherosc...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Atherosclerosis
Main Authors: Goedeke, Leigh, Rotllan, Noemi, Ramírez, Cristina M., Aranda, Juan F., Canfrán-Duque, Alberto, Araldi, Elisa, Fernández-Hernando, Ana, Langhi, Cedric, de Cabo, Rafael, Baldán, Ángel, Suárez, Yajaira, Fernández-Hernando, Carlos
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4975922/
https://ncbi.nlm.nih.gov/pubmed/26520906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atherosclerosis.2015.09.033
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares